NVIC Articles

Disease-Vaccine-Landing-Page

Disease-Vaccine-Landing-Page

Latest articles

Browse Articles

Placeholder image
Page

In August of 1999, the Committee on Government Reform launched an investigation into Federal vaccine policy as it pertained to possible conflicts of interest among Federal policy-makers. The Committee focused...

Placeholder image
Page

On March 19, 1999, the CDC published its recommendation on the use of RotaShield vaccine and reported that five cases of intussusception, a serious bowel blockage requiring medical attention, had...

Placeholder image
Page

Prior to the vaccine’s approval, Dr. Margaret Reynolds of the U.S. Rotavirus Efficacy Group presented information on the U.S. pre-licensing clinical trials at the February 12-13, 1997 CDC Advisory Committee...

Placeholder image
Page

Ages: ROTARIX live oral vaccine is approved for use in infants between the ages of six and 24 weeks (see GlaxoSmithKline product insert for recommended schedule and other indications.)Description: ROTARIX...

Placeholder image
Page

Ages: RotaTeq live oral vaccine is approved for use in infants between the ages of six and 32 weeks (see Merck product insert for recommended schedule and other indications.)Description: RotaTeq...

Placeholder image
Page

Since the introduction of vaccines targeting rotavirus, vaccine-derived rotavirus strains have also been detected and studies have found that shedding of these viruses do occur and can persist for weeks...

Placeholder image
Page

In 2006, when RotaTeq, the second oral live rotavirus vaccine received approval for use in the United States, the most common rotavirus serotypes were P1A[8]G1, P1B[4] G2, P1A[8] G3, P1A[8]...

Placeholder image
Page

By the spring of 1999, however, several reports of intussusception following RotaShield vaccine administration had been made to the Vaccine Adverse Events Reporting System (VAERS) and on July 16, 1999,...

Placeholder image
Page

On August 31, 1998, the first vaccine targeting rotavirus, RotaShield, received FDA approval for use in children. At this time, health officials estimated that 2.7 million children under the age...

Placeholder image
Page

According to data released December 27, 2024 by the CDC, 7,128 adverse reactions, including 60 deaths and 477 hospitalizations, have been reported to the Vaccine Adverse Events Reporting System (VAERS). ...

Topics
Select disease / vaccine